XDx Registers for IPO

Brisbane, Calif.-based biotech firm XDx Inc. on Wednesday announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed initial public offering of its common stock.

XDx specializes in molecular diagnostics for the monitoring of transplant rejection and autoimmune diseases.

Just Posted

Traffic looking for a shortcut will get steered off Page Street

Drivers be warned: If you’re looking to circumvent Oak Street traffic to… Continue reading

BART reporting death on train at South Hayward Station

BART’s South Hayward station is closed Tuesday afternoon after a fatality aboard… Continue reading

Battle brews within SF police union over leadership style

Gary Delagnes-endorsed candidate to challenge Tony Montoya for presidency

Protesters demonstrate against Salesforce outside Dreamforce conference

Immigrants rights advocates with Bay Resistance, Coalition to Close the Concentration Camps… Continue reading

Cultural district to honor Native American legacy in Mission

Half a century after activists occupied Alcatraz in a historic movement for… Continue reading

Most Read